生物活性

• 描述Rosiglitazone hydrochloride is a blood glucose-lowering drug, stimulating insulin secretion by binding to the PPAR receptors in fat cells.
• 临床研究

• NCT号	适应症或疾病	临床期	招募状态	预计完成时间	地点
  NCT00484419	Type 2 Diabetes ... more >> Hyperlipidemia Collapse <<	Phase 3	Completed	-	United States, California ... more >> La Mesa, California, United States Los Angeles, California, United States Los Gatos, California, United States San Antonio, California, United States United States, Florida Chiefland, Florida, United States United States, Indiana Gary, Indiana, United States United States, Maryland Baltimore, Maryland, United States United States, Michigan Dearborn, Michigan, United States W. Bloomfield, Michigan, United States United States, Nevada Las Vegas, Nevada, United States United States, New York Yonkers, New York, United States United States, North Carolina Lexington, North Carolina, United States Winston-Salem, North Carolina, United States United States, Ohio Munroe Falls, Ohio, United States Zaneville, Ohio, United States United States, Oregon Portland, Oregon, United States United States, Pennsylvania Jersey Shore, Pennsylvania, United States United States, South Carolina Clemson, South Carolina, United States United States, Tennessee Harriman, Tennessee, United States United States, Texas Dallas, Texas, United States Collapse <<
  NCT00680745	Type 2 Diabetes	Phase 3	Completed	-	-
  NCT00484419	-	-	Completed	-	-

• 更多